| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | -5.8% | JP Morgan | $110 → $107 | Maintains | Underweight |
| 10/02/2023 | -25.17% | Morgan Stanley | $86 → $85 | Maintains | Underweight |
| 08/14/2023 | -24.29% | Morgan Stanley | $84 → $86 | Maintains | Underweight |
| 08/11/2023 | -3.16% | JP Morgan | → $110 | Initiates Coverage On | → Underweight |
| 08/09/2023 | 1.24% | Susquehanna | $104 → $115 | Maintains | Neutral |
| 08/09/2023 | 1.24% | Stephens & Co. | $105 → $115 | Maintains | Equal-Weight |
| 07/19/2023 | 1.24% | Stifel | $99 → $115 | Maintains | Hold |
| 07/06/2023 | -26.05% | Morgan Stanley | $85 → $84 | Maintains | Underweight |
| 05/03/2023 | -16.37% | Barclays | $90 → $95 | Maintains | Underweight |
| 04/04/2023 | -24.29% | Morgan Stanley | $87 → $86 | Maintains | Underweight |
| 02/27/2023 | -23.41% | Morgan Stanley | $90 → $87 | Maintains | Underweight |
| 02/22/2023 | -11.96% | Wells Fargo | $95 → $100 | Maintains | Underweight |
| 12/01/2022 | -20.77% | Morgan Stanley | $86 → $90 | Maintains | Underweight |
| 11/22/2022 | -16.37% | Wells Fargo | → $95 | Downgrades | Equal-Weight → Underweight |
| 10/13/2022 | -20.77% | Barclays | $95 → $90 | Maintains | Underweight |
| 10/03/2022 | -24.29% | Morgan Stanley | $94 → $86 | Maintains | Underweight |
| 07/15/2022 | -14.61% | Wells Fargo | $101 → $97 | Maintains | Equal-Weight |
| 07/13/2022 | -16.37% | Barclays | $105 → $95 | Maintains | Underweight |
| 07/12/2022 | — | Wolfe Research | Downgrades | Peer Perform → Underperform | |
| 05/04/2022 | -11.08% | Wells Fargo | $97 → $101 | Maintains | Equal-Weight |
| 04/05/2022 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 03/16/2022 | — | Benchmark | Initiates Coverage On | → Hold | |
| 02/28/2022 | -17.25% | Morgan Stanley | $95 → $94 | Maintains | Underweight |
| 02/23/2022 | 1.24% | Susquehanna | $130 → $115 | Maintains | Neutral |
| 02/23/2022 | 1.24% | Wells Fargo | $125 → $115 | Maintains | Equal-Weight |
| 01/14/2022 | -7.56% | Barclays | $100 → $105 | Maintains | Underweight |
| 12/02/2021 | -16.37% | Morgan Stanley | → $95 | Downgrades | Equal-Weight → Underweight |
| 11/03/2021 | 10.04% | Wells Fargo | $118 → $125 | Maintains | Equal-Weight |
| 10/14/2021 | 3.88% | Wells Fargo | $131 → $118 | Maintains | Equal-Weight |
| 10/04/2021 | -7.56% | Morgan Stanley | $98 → $105 | Maintains | Equal-Weight |
| 08/30/2021 | -11.96% | Barclays | $96 → $100 | Maintains | Underweight |
| 07/27/2021 | 18.85% | Vertical Research | → $135 | Downgrades | Buy → Hold |
| 07/13/2021 | 15.33% | Wells Fargo | $123 → $131 | Maintains | Equal-Weight |
| 07/08/2021 | -13.72% | Morgan Stanley | $91 → $98 | Maintains | Equal-Weight |
| 05/10/2021 | -19.89% | Morgan Stanley | $88 → $91 | Maintains | Equal-Weight |
| 05/05/2021 | 2.12% | Susquehanna | $87 → $116 | Maintains | Neutral |
| 04/06/2021 | -22.53% | Morgan Stanley | $78 → $88 | Maintains | Equal-Weight |
| 02/22/2021 | -31.33% | Morgan Stanley | $74 → $78 | Maintains | Equal-Weight |
| 02/17/2021 | -23.41% | Credit Suisse | $85 → $87 | Maintains | Underperform |
| 01/06/2021 | -34.85% | Morgan Stanley | $72 → $74 | Maintains | Equal-Weight |
| 11/09/2020 | -36.61% | Morgan Stanley | $67 → $72 | Maintains | Equal-Weight |
| 10/05/2020 | -41.02% | Morgan Stanley | $64 → $67 | Maintains | Equal-Weight |
| 09/24/2020 | -14.61% | Wells Fargo | → $97 | Initiates Coverage On | → Equal-Weight |
| 08/10/2020 | -43.66% | Morgan Stanley | $60 → $64 | Maintains | Equal-Weight |
| 05/11/2020 | -47.18% | Morgan Stanley | $59 → $60 | Maintains | Equal-Weight |
| 05/06/2020 | -44.54% | UBS | $60 → $63 | Maintains | Sell |
| 05/06/2020 | -41.9% | Credit Suisse | $62 → $66 | Maintains | Underperform |
| 04/17/2020 | -36.61% | Barclays | $81 → $72 | Maintains | Equal-Weight |
| 04/08/2020 | -48.06% | Morgan Stanley | $60 → $59 | Maintains | Equal-Weight |
| 02/19/2020 | -29.57% | Baird | $78 → $80 | Maintains | Neutral |
| 02/19/2020 | -40.14% | UBS | $66 → $68 | Maintains | Sell |
| 01/21/2020 | -40.14% | Credit Suisse | $70 → $68 | Maintains | Underperform |
| 01/06/2020 | -45.42% | Morgan Stanley | $61 → $62 | Maintains | Equal-Weight |
| 11/11/2019 | -46.3% | Morgan Stanley | $59 → $61 | Maintains | Equal-Weight |
| 11/06/2019 | -31.33% | Baird | $77 → $78 | Maintains | Neutral |
| 11/06/2019 | -38.37% | Credit Suisse | $67 → $70 | Maintains | Underperform |
| 10/02/2019 | -36.61% | Barclays | $78 → $72 | Downgrades | Overweight → Equal-Weight |
| 08/05/2019 | -36.61% | Stifel | $73 → $72 | Maintains | Hold |
| 07/10/2019 | -38.37% | Goldman Sachs | → $70 | Initiates Coverage On | → Sell |
| 05/31/2019 | -31.33% | Loop Capital | → $78 | Initiates Coverage On | → Hold |
| 12/07/2018 | -40.14% | Goldman Sachs | → $68 | Downgrades | Neutral → Sell |
What is the target price for Expeditors Intl (EXPD)?
The latest price target for Expeditors Intl (NASDAQ: EXPD) was reported by JP Morgan on November 8, 2023. The analyst firm set a price target for $107.00 expecting EXPD to fall to within 12 months (a possible -5.80% downside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Expeditors Intl (EXPD)?
The latest analyst rating for Expeditors Intl (NASDAQ: EXPD) was provided by JP Morgan, and Expeditors Intl maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Expeditors Intl (EXPD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Expeditors Intl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Expeditors Intl was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Expeditors Intl (EXPD) correct?
While ratings are subjective and will change, the latest Expeditors Intl (EXPD) rating was a maintained with a price target of $110.00 to $107.00. The current price Expeditors Intl (EXPD) is trading at is $113.59, which is out of the analyst's predicted range.